Delivery Order SPE2DE24D0021-SPE2D625F1CHA
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,911.80 on September 3, 2025, for the supply of a kit for reverse transcription polymerase chain reaction (RT PCR) 96-well plate region of interest testing. The contract is a fixed price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 15, 2025. The award was made without a set-aside designation through open competition, and performance will take place in...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $10,700.70 on August 13, 2025, for the supply of SSIII 1-Step QRT-PCR 500 quantitative reverse transcription polymerase chain reaction testing kits. The contract, which represents a child award under a larger vehicle, is funded by the Defense Medical Supply Chain and is scheduled for completion by September 4, 2025. Performance will take place in Pittsburgh, Pennsylvania. No small business set-aside was...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $8,325.00 on August 22, 2025, for the procurement of PCR (polymerase chain reaction) IV 1st strand superscript reagents in 50 reaction quantities. This fixed-price contract with economic price adjustment provisions will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 5, 2025. The contract was awarded without set-aside designation through open competition to the Defense or Civilian...
- Fisher Scientific Company L.L.C. has been awarded a fixed-price delivery order valued at $6,420.42 for one kit of real-time polymerase chain reaction (PCR) DNA primer with single-step substrate and caption plates, to be delivered to Pittsburgh, Pennsylvania. The contract was awarded on August 28, 2025, with an ultimate completion date of September 17, 2025. This delivery order represents a child contract with no set-aside designation, awarded through open competition to support the Medical...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract valued at $2,934.90 on September 3, 2025, by the Defense Department's Medical Supply Chain division for the procurement of National Flu/RSV/COVID positive test kits in 6x 0.5mL Reagent Use Only (RUO) format. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and has an ultimate completion date of September 10, 2025. Performance will take place in Pittsburgh, Pennsylvania. This...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $17,174.10 on August 7, 2025, for the procurement of PCR (polymerase chain reaction) system reagents—specifically SYS PCR IV 1st Strain Superscript 50 reaction kits. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 18, 2025, and will be performed at Fisher Scientific's location in Pittsburgh, PA. The contract was awarded without a set-aside designation, reflecting open...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,230.00 on August 22, 2025, for the procurement of a kit containing real-time polymerase chain reaction (PCR) DNA primer with a single-step protocol and probe for detection purposes. The contract, which is fixed price with economic price adjustment pricing, is classified as a child contract and was issued without a set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, with an ultimate completion...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,782.05 for FG TaqMan Fast Universal PCR supplies on July 29, 2025, with an ultimate completion date of August 8, 2025. This fixed-price contract with economic price adjustment was awarded without a set-aside designation by the Medical Supply Chain division of the Defense Department. The work will be performed in Pittsburgh, Pennsylvania. As a child contract under a larger vehicle, this delivery order represents a discrete...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order valued at $1,467.45 from the Medical Supply Chain, a defense-oriented federal agency, for the procurement of National Flu/RSV/COVID positive test kits (6x0.5mL, research use only). The contract, awarded on July 28, 2025, with an ultimate completion date of August 4, 2025, represents a child contract under a larger vehicle and will be performed in Pittsburgh, PA. This award reflects Fisher Scientific's established role as a...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 7, 2025, valued at $4,929.58 for the procurement of a real-time PCR (polymerase chain reaction) 1ml DNA multiplex master mix kit. This fixed-price delivery order with economic price adjustment terms is set to be completed by August 14, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Medical Supply Chain division of the Department of Defense through open competition with no set-aside...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F1CHADelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,260.00 on August 15, 2025, for the procurement of kit reverse transcription polymerase chain reaction (RT-PCR) reagents with reduced ribonucleic acid (RNA) activity. This fixed-price delivery order with economic price adjustment falls under the Defense or Civilian agency designation of Medical Supply Chain and is scheduled for completion by August 29, 2025. The contract represents a child award and does not utilize a set-aside designation, indicating open competition procurement. Performance is to be executed in Pittsburgh, Pennsylvania. As a major federal supplier of laboratory and scientific products, Fisher Scientific leverages its established capabilities to support government healthcare and research initiatives. The company maintains significant contract relationships across multiple federal agencies, including the National Institutes of Health, Department of Veterans Affairs, and various defense-related organizations. This particular delivery order contributes to the Medical Supply Chain's requirements for specialized molecular biology testing reagents, supporting diagnostic and research capabilities within the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/15/25 |